Duloxetine Reduces Pain and Improves Quality of Recovery Following the Repair of Rotator Cuff Injury

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035105

Enrollment

Unknown

Registered

2020-07-31

Start date

2020-08-10

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff injury

Interventions

experimental group:duloxetine 30mg bid

control group:without duloxetine

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Eligible patients with age >=18 years old; 2. Patients who have been assigned to ASA class I, II or III; 3. Patients scheduled for rotator cuff injury repair surgery.

Exclusion criteria

Exclusion criteria: 1. Patients who have used duloxetine; 2. Patients with a known mental illness; 3. Patients with intolerance or allergy to any study drug; 4. Patients with alcohol or opioid dependence, and patients with renal or liver function impairment.

Design outcomes

Primary

Measure	Time frame
pain;	—

Countries

China

Contacts

Public ContactJian Li

West China Hospital of Sichuan University

lijianhx6@163.com+86 17882085169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026